Over the past 12 months, Ozempic and similar drugs have been hailed in the news as miracle solutions for rapid weight loss with minimal side effects. Weight loss often happens because of the changes in food and beverage consumption that these drugs trigger. In this episode of Consumer Foods to Go, Maria Castroviejo and Cyrille Filott discuss the impact of GLP-1 drugs on the food sector with podcast regular Nick Fereday. There is an impact, but much remains unknown.
Podden och tillhörande omslagsbild på den här sidan tillhör Rabobank. Innehållet i podden är skapat av Rabobank och inte av, eller tillsammans med, Poddtoppen.
